1)Tam NN, Gao Y, Leung YK, et al:Androgenic regulation of oxidative stress in the rat prostate:involvement of NAD(P)H oxidases and antioxidant defense machinery during prostatic involution and regrowth. Am J Pathol 163:2513-2522, 2003
2)Chen Z, Trotman LC, Shaffer D, et al:Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436:725-730, 2005
3)Konishi N, Enomoto T, Buzard G, et al:K-ras activation and ras p21 expression in latent prostatic carcinoma in Japanese men. Cancer 69:2293-2299, 1992
4)Suzuki S, Shiraga K, Sato S, et al:Apocynin an NADPH oxidase inhibitor, suppresses rat prostate carcinogenesis. Cancer Sci, 2013 Sep 30. doi:10.1111/cas. 12292.[Epub ahead of print]
5)Allott EH, Masko EM and Freedland SJ:Obesity and prostate cancer:weighing the evidence. Eur Urol 63:800-809, 2013
6)Seeni A, Takahashi S, Takeshita K, et al:Suppression of prostate cancer growth by resveratrol in the transgenic rat for adenocarcinoma of prostate(TRAP)model. Asian Pac J Cancer Prev 9:7-14, 2008
7)Long N, Suzuki S, Sato S, et al:Purple corn color inhibition of prostate carcinogenesis by targeting cell growth pathways. Cancer Sci 104:298-303, 2013
8)Shirai T, Iwasaki S, Masui T, et al:Enhancing effect of cadmium on rat ventral prostate carcinogenesis induced by 3,2'-dimethyl-4-aminobiphenyl. Jpn J Cancer Res 84:1023-1030, 1993
9)Nakayama M, Bennett CJ, Hicks JL T, et al:Hypermethylation of the human glutathione S-transferase-pi gene(GSTP1)CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate:a detailed study using laser-capture microdissection. Am J Pathol 163:923-933, 2003
10)Ripple MO, Henry WF, Rago RP T, et al:Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells. J Natl Cancer Inst 89:40-48, 1997